Syria’s Minister of Transport, Yarub Badr, held talks on Thursday with representatives from Dorsch Global, a German company specializing in railway infrastructure, to discuss the upgrade of the phosphate transport rail line from the Homs mines to the port of Tartous. The project aims to increase the line’s annual capacity to 4.3 million tons.
During a video conference, Minister Badr invited the German team to conduct a field visit to the rail line, from the mines to the port, to assess the technical condition on-site, identify specific needs, and ensure the accuracy of the studies before proceeding with the project.
The discussions centered on the technical and logistical challenges of upgrading the infrastructure and improving the technologies used in the rail system. The proposed upgrades are expected to enhance the efficiency of phosphate transport, streamlining the movement of goods from production areas to the port.
This meeting follows a similar one held on Wednesday with representatives from the Friedrich Naumann Foundation, a German organization specializing in research and technical support. That discussion focused on developing Syria’s transport sector, including providing technical assistance to the Ministry of Transport.
Hence then, the article about transport minister discusses with german firm developing phosphate rail line capacity was published today ( ) and is available on SANA ( Syria ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Transport Minister discusses with German firm developing phosphate rail line capacity )
Also on site :
- My Daughter’s Friend Has a Crush on My Husband. It’s Making Us Both Deeply Uncomfortable.
- Manchester United vs Newcastle Prediction: Heavyweights Meet in Premier League’s Only Boxing Day Clash
- Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline